Drug users under the microscope: Temo’s experience in Georgia
“I was in prison when I was diagnosed with Hepatitis B,” says Temo, 33. “I was just left with the...
Read more about Drug users under the microscope: Temo’s experience in Georgia
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
Read more about Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
Politics of Death: The End of Brazil’s Department of AIDS
Adapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
Read more about Politics of Death: The End of Brazil’s Department of AIDS
Pipeline patents – Brazilian Supreme Court decides on the present and the future
On Wednesday 22 May, the largest trial in the history of the Brazilian Federal Supreme Court (STF) involving the pharmaceutical...
Read more about Pipeline patents – Brazilian Supreme Court decides on the present and the future
Truvada for PrEP. Gilead grilled at US congressional hearing
The USA is being charged $70 per pill for a drug, yet tax payers largely funded the research. Thanks to...
Read more about Truvada for PrEP. Gilead grilled at US congressional hearing
What’s wrong with IP rights? Protecting medicines from competition can be costly
Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development,...
Read more about What’s wrong with IP rights? Protecting medicines from competition can be costly
Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
GTPI has presented an argument to the Brazilian Patent Office (INPI) to invalidate the patent granted for the drug daclatasvir....
Read more about Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
Kularb’s story: Optimal treatment would reduce HIV-related stigma
“I was told I’d have to wait for 10 more people to die before I could get treatment.” Kularb found...
Read more about Kularb’s story: Optimal treatment would reduce HIV-related stigma
Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
The All-Ukrainian Network of People Living with HIV/AIDS (the Network) has received an official letter from Merck, dated 15 March...
Read more about Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
Watching Brazil: In defence of democracy and human rights
Author: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
Read more about Watching Brazil: In defence of democracy and human rights